statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harpoon Therapeutics, Inc. (NASDAQ:HARP  Get Free Report) major shareholder Merck & Co., Inc. purchased 21,397,205 shares of the companys stock in a transaction that occurred on Monday...

Harpoon Therapeutics, Inc. (NASDAQ:HARP) Major Shareholder Merck & Co., Inc. Acquires 21,397,205 Shares

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Harpoon Therapeutics, Inc. (Nasdaq: HARP). Harpoon is now a wholly-owned...

Merck Completes Acquisition of Harpoon Therapeutics, Inc.

HARP's total volume now sits at 6.4M. The +0.17% average daily price change was insignificant these 2 days, leaving HARP's price at $23.01...

The volume for Harpoon Therapeutics stock increased for two consecutive days, resulting in a record-breaking daily growth of 326% of the 65-Day Volume Moving Average

Harpoon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Merck...

Harpoon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Merck

Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP  Get Free Report) have been assigned a consensus rating of Hold from the six research firms that are currently covering the...

Brokerages Set Harpoon Therapeutics, Inc. (NASDAQ:HARP) Target Price at $24.75

HARP's total volume now sits at 1.6M. The +2.27% average daily price change was insignificant these 4 days, leaving HARP's price at $22.93...

The volume for Harpoon Therapeutics stock increased for four consecutive days, resulting in a record-breaking daily growth of 230% of the 65-Day Volume Moving Average

This is a signal that HARP's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Harpoon Therapeutics (HARP, $22.96) Stochastic Oscillator left the oversold zone on February 22, 2024

HARP's total volume now sits at 5.6M. The +2.41% average daily price change was insignificant these 3 days, leaving HARP's price at $22.96...

The volume for Harpoon Therapeutics stock increased for three consecutive days, resulting in a record-breaking daily growth of 282% of the 65-Day Volume Moving Average

HARP's total volume now sits at 2.3M. The +0.89% average daily price change was insignificant these 2 days, leaving HARP's price at $22.62...

The volume for Harpoon Therapeutics stock increased for two consecutive days, resulting in a record-breaking daily growth of 167% of the 65-Day Volume Moving Average

This price move could be a signal that HARP may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Harpoon Therapeutics (HARP, $22.62) price may drop as it broke higher Bollinger Band on Feb 21, 2024

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA.

Watchers	1,576
52-Wk Low	$3.11
52-Wk High	$23.21

Volume	6.62M
52-Wk High	$23.21
52-Wk Low	$3.11

HARP Harpoon Therapeutics Inc

About

Feed

News

Fundamentals